Product :
LY2886721
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
| Product name：LY2886721 |
Purity：98% min |
| CAS NO：1262036-50-9 |
Solubility：DMSO : ≥ 42 mg/mL (107.58 mM) |
| Molecular Formula：C18H16F2N4O2S |
Package：Package according to customer requirements |
| Molecular Weight：390.407 |
Storage：Store at -20℃ |
Remarks
LY2886721 is a potent and selective BACE1 inhibitor. LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans. LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclinical animal models. Similar potent and persistent amyloid β lowering was observed in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects. BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).